Cardiawave SA has published six-month clinical data from its ongoing, first-in-human Valvosoft® studies to treat severe symptomatic calcific aortic valve stenosis.
The device delivers focused ultrasound to calcified aortic valves to soften the valve leaflets and improve function.
The Foundation and Arms Wide Open Childhood Cancer Foundation are funding a research project exploring focused ultrasound for high-risk pediatric neuroblastoma.
A team at the University of Chicago will evaluate how focused ultrasound impacts the immune microenvironment in a preclinical model.
Theraclion announced that it has officially launched its US pivotal clinical trial using the Sonovein focused ultrasound system to treat varicose veins.
The first patients were enrolled in New Jersey, and others who are interested in participating are now encouraged to contact the site.
A team at Columbia University published preclinical and clinical data suggesting focused ultrasound blood-brain barrier opening reduced two types of pathology in Alzheimer’s brains.
Preliminary results from the human clinical trial showed a temporary decrease of amyloid in the treated area.
A one-day meeting at the Princess Maxima Center in the Netherlands will address therapeutic ultrasound for the brain, including blood-brain barrier opening, ablation, neuromodulation, and more.
Registration is now open, and abstracts are due by January 15.
“We firmly believe that it will require collaboration and groundbreaking ideas to unearth effective immunotherapies for aggressive cancers, such as the one that claimed our beloved son, Andrew.”